Considering exosome stem cell injections for hairloss alongside minoxidil and finasteride. Some suggest trying dutasteride first due to its proven effectiveness.
RU58841 is used topically to prevent hairloss by blocking DHT, with suggestions to drink grapefruit juice, take breaks, avoid microneedling, and use lower concentrations to reduce side effects. Users discuss applying it at night to minimize systemic absorption.
RU58841 is discussed as a potential hairloss treatment, with comparisons to finasteride. There is interest in leaked trial data, but no official clinical validation or approval for RU58841.
PP405 is not a cure for hairloss but may reactivate dormant hair follicles, similar to minoxidil. It is unlikely to help with miniaturized or vellus hairs and is still in trial phases, with availability expected around 2030.
Microneedling is preferred over laser therapy for hairloss because it is cheaper and reportedly effective, especially with minoxidil. Laser therapy is seen as costly and less effective.
Oral minoxidil is effective for hairloss but can cause cardiovascular side effects, such as pericardial effusion, especially in those with genetic predispositions. Starting with low doses and monitoring cardiovascular health are advised to reduce risks.
RU58841 has mixed reviews for hairloss, with some users reporting success and others experiencing no benefits or side effects. Alternatives like finasteride and minoxidil are preferred by some due to safety concerns with RU58841.
KX826 shows promise as a hairloss treatment with a 10% increase in hair count, but concerns about Kintor's marketing practices and the systemic effects of treatments like GT20029 and RU58841 remain. Users express skepticism and hope, with some preferring traditional treatments like finasteride and minoxidil.
Dutasteride and finasteride are used for hairloss, affecting hormone levels like DHT and testosterone. Hormone balance is crucial, as changes can lead to side effects such as increased estradiol and potential hairloss.
Vitamin D deficiency is linked to hairloss, and supplementation with vitamin D can improve conditions like androgenic alopecia and telogen effluvium. Users discussed various dosages of vitamin D, emphasizing the importance of getting blood tests to determine the appropriate amount.
Scalp biopsies are crucial for diagnosing hairloss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hairloss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.
Results for Amplifica's AMP-303 hairloss treatment study are expected late summer 2024. The study, fully enrolled in Q1 2024, focuses on safety and tolerability.
A user found a successful hairloss treatment using a combination of finasteride, dutasteride, minoxidil, and RU58841. They plan to switch to a purely topical regimen with finasteride, RU58841, and minoxidil.
The user discusses using Minoxidil for hairloss and is considering RU58841 to reduce excessive oil production. They seek advice on RU58841's effectiveness in blocking sebum production.
The conversation discusses using tretinoin for hairloss and skincare. Users share experiences, noting tretinoin's effectiveness in combination with minoxidil for hair and its proven benefits for anti-aging skincare.
Finasteride and Dutasteride are effective treatments for hairloss, with Dutasteride being superior based on long-term data. Side effects are minimal, and concerns should not deter treatment.
The DHT itch is linked to hairloss and persists despite finasteride use; switching to dutasteride helped alleviate the itch and promoted regrowth. Some users suggest seborrheic dermatitis as a cause and recommend treatments like medicated shampoos, vitamin D, and minoxidil.
Progesterone cream might help with hairloss by inhibiting DHT production and suppressing prolactin, which can increase DHT. Some dermatologists have used progesterone for hairloss treatment, and it has been effective, sometimes combined with minoxidil, finasteride, and hydrocortisone.
A user has been experiencing hairloss for 4 years, with treatments like minoxidil, finasteride, and various supplements proving ineffective. They were diagnosed with fibrosing alopecia in a pattern distribution, a condition that may require a combination of anti-inflammatory and hair growth treatments.
A user is starting treatment for hairloss with topical minoxidil, oral finasteride, and is considering adding topical latanoprost but is unsure about the application frequency and method for latanoprost. They are seeking advice from others with experience using these treatments.
The conversation discusses the potential of new hairloss treatments, with a focus on pyrilutamide, gt20029, and topical alfatradiol, and the possibility of improving their effectiveness through methods like increased concentration and microneedling. Dutasteride is also mentioned as a stronger option.
Kintor is testing Pyrilutamide with Minoxidil for hairloss. Users are skeptical about its effectiveness and concerned about limited treatment options if this fails.
The conversation discusses patient updates on hairloss treatment with Verteporfin after five months, as reported by Dr. Blake Bloxham. Patients voluntarily sent their progress pictures to Dr. Bloxham.